The AGA Quality Committee, in collaboration with the Rome Foundation, has developed nine evidence-based quality indicators for irritable bowel syndrome (IBS), covering evaluation, diagnosis, and management. These include taking a detailed patient history, testing for celiac disease in IBS-D or IBS-M patients, using fecal calprotectin for IBS-D evaluation, and avoiding routine colonoscopy in IBS patients without alarm features.
Keep Reading
Add A Comment